Congenital muscular dystrophy
|Congenital muscular dystrophy|
|Classification and external resources|
Congenital muscular dystrophies are autosomal recessively-inherited muscle diseases. They are a group of heterogeneous disorders characterized by muscle weakness which is present at birth and the different changes on muscle biopsy that ranges from myopathic to overtly dystrophic due to the age at which the biopsy takes place.
Classification(Different types of Congenital muscular dystrophies)
The subtypes of congenital muscular dystrophy have been established through variations in multiple genes. It should be noted that phenotype, as well as, genotype classifications are used to establish the subtypes, in some literature. Individuals who suffer from congenital muscular dystrophy fall into one of the following types:
- CMD with brain-eye
- a rare form of congenital muscular dystrophy (autosomal
- recessive disorder) causing a lack of normal
- muscle tone which can delay walking due to being weak,
- also paralysis of eye muscles and intellectual disability
- which affects an individuals way of processing information
- CMD with adducted (drawn inward) thumbs. a rare form of CMD causing permanent shortening of the toe joints and lack of muscle tone which can delay walking due to the individual being weak. The person with this form of congenital muscular dystrophy might have mild cerebellar hypoplasia in some cases .
- CMD/LGMD without MR -first years of a newborn begins with weakness, which affects motive skills, walking can be accomplished in adolescence, deformity and rigidity of joints. The joints, neck and spine; progressive cardiomyopathy at the early ages; cardiac rhythm abnormalities may be present in the individual. 
- Large related CMD at the beginning of the newborn period, the issues the infant receives are; poor muscle tone and weak motor function; the individual will present with mental retardation and the structure of the brain will likely be abnormal .
- CMD with cerebellar atrophy  severe cerebellar hypoplasia, poor muscle tone, delayed in motor milestones, lack of coordination in motive skills, difficulty speaking, involuntary movements and some intellectual disability. Furthermore, muscle biopsy does not reveal any deficiency.
- Walker–Warburg syndrome  at the beginning a progressive weakness and low muscle tone at birth or during early infancy; small muscles; the majority of affected children do not live more than 3 years of age. Eye structure problems are present, with accompanying visual impairment.
- CMD with primary laminin-α2 (merosin) deficiency (MDC1A)  intellect in such individuals is unaffected, proximal muscle weakening and rigid spine are present along with respiratory involvement (with disease progression).
- CMD/LGMD with MR  weakness and deformity and rigidity joints present at birth, poor muscle tone, slowly progressive; individuals may present with cerebellar cysts (or cortical problems), microcephaly may be present as well. Abnormal flexibility might occur, spinal curvature possible.
- CDG I (DPM3)  some of the symptoms at birth and through out the infants life are weakness or poor muscle tone. The individual may present with cardiomyopathy (no outflow obstruction), a rise in serum creatine kinase might be present as well. Some IQ problems may be present, along with weakness in the proximal muscles. Also of note, a reduction of dolichol phosphate mannose .
- CDG I (DPM2)  weak muscle tone starting in first weeks of the infant, the individual may show severe neurologic physical characteristics that result in fatality early in life. Hypotonia and myopathic facies may be present in such individuals, while contractures of joints may also be present. Finally, myoclonic seizures may occur at a very early age (3 months).
- CDG Ie (DPM1)  at birth the infant will have weakness with involvement of the respiratory system , as well as, severe mental and psychomotor problems.By age of 3,the individual may be blind with speech problems. Microcephaly may occur in early childhood, as well as seizures.
- CMD with spinal rigidity  present at birth can have poor muscle tone and weakness, reduced respiratory capacity, muscles could be deformed, beginning early ages stabilization or slow decline spinal rigidity, limited mobility to flex the neck and spine, spinal curvature and progressing deformity and rigidity joints, minor cardiac abnormalities, normal intelligence.
- CMD with lamin A/C abnormality with in the first year the infant is weak, individual may have problems later lifting arms and head. May need nasogastric tube, limb weakness and elevated serum creatine kinase. Individual may show a diaphragmatic manner when breathing.
- Integrin α7  weakness which is present at birth, poor muscle tone with late walking, loss of muscle tissue, intellectual disability.Furthermore, the creatine kinase level was elevated.
- Fukuyama CMD -in western countries this type of CMD is rare but is common in Japan. The effects this disease has on infants is spectrum of severity, weakness in muscle tone within first year, some infants may achieve some walking, have deformity and rigidity joints, spinal curvatures, seizures, eye involvement and intellectual disability.
- Merosin-deficient CMD - present at birth weakness in muscle tone, spectrum of severity; may show hypotonia, and poor motot development. Most individuals have periventricular white matter problems. However, mental retardation is rare in most cases.
- Merosin-positive CMD  some forms of merosin-positive CMD are: Early spinal rigidity, CMD with muscle hypertrophy, CMD with muscle hypertrophy and respiratory failure, CMD with myasthenic syndrome.
- Ullrich congenital muscular dystrophy  present at birth is weakness, poor muscle tone, will have some deformity and rigidity joints, some joints will have excessive flexibility, spinal rigidity, curvature, respiratory impairment, soft skin, normal cardiac function and normal intelligence.
Most infants with CMD will display some progressive muscle weakness or muscle wasting (atrophy), although there can be different degrees and symptoms of severeness of progression. The weakness is indicated as hypotonia, or lack of muscle tone, which can make an infant seem unstable.
Children may be slow with their motor skills; such as rolling over, sitting up or walking, or may not even reach these milestones of life. Some of the more rarer forms of CMD can result in significant learning disabilities.[medical citation needed]
The genetics of congenital muscular dystrophy are autosomal recessive which means two copies of an abnormal gene must be present for the disease or trait to happen. In the case of collagen VI-deficient, it is autosomal dominant, which means you could inherit the gene in question from one parent.
The prevalence for congenital muscular dystrophy seems to be between 2.6-4.5 in 10,000 according to Reed, 2009. MDCIA, for example is due to a mutation in the LAMA-2 gene and is involved with the 6q2 chromosome.
In terms of the diagnosis on congenital muscular dystrophy, the following tests/exams are done:
In terms of the management of congenital muscular dystrophy the American Academy of Neurology recommends that the individuals need to have monitoring of cardiac function, respiratory, and gastrointestinal. Additionally it is believed that therapy in speech, orthopedic and physical areas, would improve the persons quality of life.
While there is currently no cure available, it is important to preserve muscle activity and any available correction of skeletal abnormalities (as scoliosis).Orthopedic procedures, like spinal fusion, maintains/increases the individuals prospect for more physical movement.
- Sparks, Susan; Quijano-Roy, Susana; Harper, Amy; Rutkowski, Anne; Gordon, Erynn; Hoffman, Eric P.; Pegoraro, Elena (1993-01-01). Pagon, Roberta A.; Adam, Margaret P.; Ardinger, Holly H.; Wallace, Stephanie E.; Amemiya, Anne; Bean, Lora JH; Bird, Thomas D.; Fong, Chin-To; Mefford, Heather C., eds. Congenital Muscular Dystrophy Overview. Seattle (WA): University of Washington, Seattle. PMID 20301468.update 2012
- Bertini, Enrico; D'Amico, Adele; Gualandi, Francesca; Petrini, Stefania (2011-12-01). "Congenital Muscular Dystrophies: A Brief Review". Seminars in Pediatric Neurology 18 (4): 277–288. doi:10.1016/j.spen.2011.10.010. ISSN 1071-9091. PMC 3332154. PMID 22172424.
- "OMIM Entry - # 253280 - MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3". www.omim.org. Retrieved 2016-04-26.
- Reference, Genetics Home. "Walker-Warburg syndrome". Genetics Home Reference. Retrieved 2016-04-26.
- Quijano-Roy, Susana; Sparks, Susan; Rutkowski, Anne (1993-01-01). Pagon, Roberta A.; Adam, Margaret P.; Ardinger, Holly H.; Wallace, Stephanie E.; Amemiya, Anne; Bean, Lora JH; Bird, Thomas D.; Fong, Chin-To; Mefford, Heather C., eds. LAMA2-Related Muscular Dystrophy. Seattle (WA): University of Washington, Seattle. PMID 22675738.update 2012
- "OMIM Entry - # 612937 - CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Io; CDG1O". www.omim.org. Retrieved 2016-04-26.
- "OMIM Entry - # 615042 - CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U". www.omim.org. Retrieved 2016-04-26.
- "OMIM Entry - # 608799 - CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie; CDG1E". www.omim.org. Retrieved 2016-04-26.
- "OMIM Entry - # 602771 - RIGID SPINE MUSCULAR DYSTROPHY 1; RSMD1". www.omim.org. Retrieved 2016-04-26.
- "OMIM Entry - # 613205 - MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED". www.omim.org. Retrieved 2016-04-26.
- "OMIM Entry - # 613204 - MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY". www.omim.org. Retrieved 2016-04-26.
- Reference, Genetics Home. "Fukuyama congenital muscular dystrophy". Genetics Home Reference. Retrieved 2016-04-26.
- "OMIM Entry - # 607855 - MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A". www.omim.org. Retrieved 2016-04-26.
- "OMIM Entry - % 609456 - MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE". www.omim.org. Retrieved 2016-04-26.
- "OMIM Entry - # 254090 - ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1; UCMD1". omim.org. Retrieved 2016-04-26.
- "Hypotonia: MedlinePlus Medical Encyclopedia". www.nlm.nih.gov. Retrieved 2016-04-28.
- Reed, Umbertina Conti. "Congenital muscular dystrophy. Part I: a review of phenotypical and diagnostic aspects". Arquivos de Neuro-Psiquiatria 67 (1): 144–168. doi:10.1590/S0004-282X2009000100038. ISSN 0004-282X.
- Reed, Umbertina (2009). "Congenital muscular dystrophy part 2" (PDF). Neuropsiquitria. Retrieved 2016.
- "Congenital Muscular Dystrophy Workup: Laboratory Studies, Imaging Studies, Other Tests". emedicine.medscape.com. Retrieved 2016-04-28.
- "Congenital muscular dystrophy". Guidelines American Academy of Neurology. 2015. Retrieved 2016.
- A, Graziano; F, Bianco; A, D'Amico; I, Moroni; S, Messina; C, Bruno; E, Pegoraro; M, Mora; G, Astrea (2015-03-01). "Prevalence of congenital muscular dystrophy in Italy: a population study.". Neurology 84 (9): 904–911. doi:10.1212/WNL.0000000000001303. ISSN 0028-3878. PMC 4351663. PMID 25653289.
- Paco, Sonia; Casserras, Teresa; Rodríguez, Maria Angels; Jou, Cristina; Puigdelloses, Montserrat; Ortez, Carlos I.; Diaz-Manera, Jordi; Gallardo, Eduardo; Colomer, Jaume (2015-12-15). "Transcriptome Analysis of Ullrich Congenital Muscular Dystrophy Fibroblasts Reveals a Disease Extracellular Matrix Signature and Key Molecular Regulators". PLOS ONE 10 (12): e0145107. doi:10.1371/journal.pone.0145107. ISSN 1932-6203. PMC 4686057. PMID 26670220.